| Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Metoject 7.5 mg | Injektionslösung | Solution injectable () | L04AX03 | IPat |
| 02 | Metoject 10 mg | Injektionslösung | Solution injectable () | L04AX03 | IPat |
| 03 | Metoject 15 mg | Injektionslösung | Solution injectable () | L04AX03 | IPat |
| 04 | Metoject 20 mg | Injektionslösung | Solution injectable () | L04AX03 | IPat |
| 05 | Metoject 25 mg | Injektionslösung | Solution injectable () | L04AX03 | IPat |
| 06 | Metoject 7.5 mg | Injektionslösung | Solution injectable (Methotrexate 7.5mg / 0.15ml) | L04AX03 | IPat |
| 07 | Metoject 10 mg | Injektionslösung | Solution injectable (Methotrexate 10mg / 0.2ml) | L04AX03 | IPat |
| 08 | Metoject 15 mg | Injektionslösung | Solution injectable (Methotrexate 15mg / 0.3ml) | L04AX03 | IPat |
| 09 | Metoject 20 mg | Injektionslösung | Solution injectable (Methotrexate 20mg / 0.4ml) | L04AX03 | IPat |
| 10 | Metoject 25 mg | Injektionslösung | Solution injectable (Methotrexate 25mg / 0.5ml) | L04AX03 | IPat |
| 11 | Metoject 30 mg | Injektionslösung | Solution injectable (Methotrexate 30mg / 0.6ml) | L04AX03 | IPat |
| 12 | Metoject 12.5 mg | Injektionslösung | Solution injectable (Methotrexate 12.5mg / 0.25ml) | L04AX03 | IPat |
| 13 | Metoject 17.5 mg | Injektionslösung | Solution injectable (Methotrexate 17.5mg / 0.35ml) | L04AX03 | IPat |
| 14 | Metoject 22.5 mg | Injektionslösung | Solution injectable (Methotrexate 22.5mg / 0.45ml) | L04AX03 | IPat |
| 15 | Metoject 27.5 mg | Injektionslösung | Solution injectable (Methotrexate 27.5mg / 0.55ml) | L04AX03 | IPat |
